Tuesday, September 22, 2020 9:37:42 AM
Average Recommendation: Overweight Average Target Price: 22.40
Number of Ratings: 12 Current Quarters Estimate: -0.90
FY Report Date: 12 / 2020 Current Year's Estimate: -4.21
Last Quarter's Earnings: -1.62 Median PE on CY Estimate: N/A
Year Ago Earnings: 2.39 Next Fiscal Year Estimate: -0.73
Median PE on Next FY Estimate: N/A
Earnings Per Share
This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12.00 11.00 12.00 12.00
Mean Estimate -0.90 -0.79 -4.21 -0.73
High Estimates -0.45 -0.47 -2.93 0.70
Low Estimates -1.60 -1.08 -5.21 -3.58
Coefficient Variance -36.44 N/A -15.37 -155.77
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM